Tracey Hylton
Psychiatric/Mental Health · Norwalk, OHNPI 1679173785
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,694, more than ten times the $15 reported in 2023.
Across 135 payments — averaging $24.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$552
- AbbVie$506
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$308
- Otsuka America Pharmaceutical, Inc.$304
- Axsome Therapeutics, Inc.$262
- Alkermes, Inc.$230
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,25198%
- Education$762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $552 |
| AbbVie | 23 | $506 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $308 |
| Otsuka America Pharmaceutical, Inc. | 10 | $304 |
| Axsome Therapeutics, Inc. | 10 | $262 |
| Alkermes, Inc. | 14 | $230 |
| Neurocrine Biosciences, Inc. | 8 | $226 |
| Braeburn Inc. | 7 | $216 |
| Johnson & Johnson | 3 | $149 |
| Vanda Pharmaceuticals Inc. | 7 | $140 |
| Collegium Pharmaceutical, Inc. | 4 | $65 |
| Exact Sciences | 3 | $51 |
| Lilly USA, LLC | 3 | $48 |
| Indivior Inc. | 2 | $46 |
| Lundbeck LLC | 1 | $27 |
| Luye Pharma (USA) Ltd. | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Corium, LLC | 1 | $16 |
| Merck | 1 | $14 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
- UZEDY$125
- Austedo XR$124
- BRIXADI$124
- Auvelity$124
- ABILIFY MAINTENA$121
- ABILIFY ASIMTUFII$121
- INVEGA SUSTENNA$120
- INVEGA TRINZA$120
How this compares
$3,327 in reported general payments places this provider in the 80th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $2,255 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Norwalk
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
- Danielle MorroneCanfield$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.